Hexafluronium
Clinical data
ATC code
Identifiers
  • N,N-di-9H-fluoren-9-yl-N,N,N',N'-tetramethylhexane-1,6-diaminium dibromide
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
ECHA InfoCard100.005.697
Chemical and physical data
FormulaC36H42Br2N2
Molar mass662.554 g·mol−1
3D model (JSmol)
  • [Br-].[Br-].c1cccc3c1c2c(cccc2)C3[N+](CCCCCC[N+](C6c4ccccc4c5ccccc56)(C)C)(C)C
  • InChI=1S/C36H42N2.2BrH/c1-37(2,35-31-21-11-7-17-27(31)28-18-8-12-22-32(28)35)25-15-5-6-16-26-38(3,4)36-33-23-13-9-19-29(33)30-20-10-14-24-34(30)36;;/h7-14,17-24,35-36H,5-6,15-16,25-26H2,1-4H3;2*1H/q+2;;/p-2 checkY
  • Key:WDEFPRUEZRUYNW-UHFFFAOYSA-L checkY
 ☒NcheckY (what is this?)  (verify)

Hexafluronium (or hexafluorenium) is a muscle relaxant.[1] It acts as a nicotinic acetylcholine receptor antagonist.

References

  1. Baraka A (August 1975). "Hexafluorenium-suxamethonium interaction in patients with normal versus atypical cholinesterase". British Journal of Anaesthesia. 47 (8): 885–8. doi:10.1093/bja/47.8.885. PMID 1201167.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.